BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 22535601)

  • 21. A surrogate marker profile for PML/RAR alpha expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypes.
    Paietta E; Goloubeva O; Neuberg D; Bennett JM; Gallagher R; Racevskis J; Dewald G; Wiernik PH; Tallman MS;
    Cytometry B Clin Cytom; 2004 May; 59(1):1-9. PubMed ID: 15108165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
    Zeleznikova T; Stevulova L; Kovarikova A; Babusikova O
    Neoplasma; 2007; 54(6):471-7. PubMed ID: 17949229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The immunophenotype of acute promyelocytic leukemia (APL): an ECOG study.
    Paietta E; Andersen J; Gallagher R; Bennett J; Yunis J; Cassileth P; Rowe J; Wiernik PH
    Leukemia; 1994 Jul; 8(7):1108-12. PubMed ID: 8035602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flow cytometry rapidly identifies all acute promyelocytic leukemias with high specificity independent of underlying cytogenetic abnormalities.
    Dong HY; Kung JX; Bhardwaj V; McGill J
    Am J Clin Pathol; 2011 Jan; 135(1):76-84. PubMed ID: 21173127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Application of CD123 in detection of minimal residual disease in acute promyelocytic leukemia].
    Wang YZ; Chang Y; Zhu HH; Qin YZ; Li JL; Fu JY; Li LD; Chen SS; Huang XJ; Lu DP; Liu YR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):427-32. PubMed ID: 16800913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute promyelocytic leukemia: Immunophenotype and differential diagnosis by flow cytometry.
    Fang H; Wang SA; Hu S; Konoplev SN; Mo H; Liu W; Zuo Z; Xu J; Jorgensen JL; Yin CC; El Hussein S; Jelloul FZ; Tang Z; Medeiros LJ; Wang W
    Cytometry B Clin Cytom; 2022 Jul; 102(4):283-291. PubMed ID: 35716019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radar plots facilitate differential diagnosis of acute promyelocytic leukemia and NPM1+ acute myeloid leukemia by flow cytometry.
    Gupta M; Jafari K; Rajab A; Wei C; Mazur J; Tierens A; Hyjek E; Musani R; Porwit A
    Cytometry B Clin Cytom; 2021 Jul; 100(4):409-420. PubMed ID: 33301193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunological classification of acute myeloblastic leukemias: relevance to patient outcome.
    Casasnovas RO; Slimane FK; Garand R; Faure GC; Campos L; Deneys V; Bernier M; Falkenrodt A; Lecalvez G; Maynadié M; Béné MC
    Leukemia; 2003 Mar; 17(3):515-27. PubMed ID: 12646939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3.
    Scott AA; Head DR; Kopecky KJ; Appelbaum FR; Theil KS; Grever MR; Chen IM; Whittaker MH; Griffith BB; Licht JD
    Blood; 1994 Jul; 84(1):244-55. PubMed ID: 7517211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cryptic PML-RARα positive acute promyelocytic leukemia with unusual morphology and cytogenetics.
    Goyal M; Dattatreya PS; Goud I; Murthy SS
    Indian J Pathol Microbiol; 2010; 53(4):817-9. PubMed ID: 21045428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Detection and analysis of immune molecules in leukemia cell surfaces of acute promyelocytic leukemia].
    Dong T; Jiang Y; Li Z; Ouyang H; Zhang Q
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 May; 33(5):664-667. PubMed ID: 28502306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel flow cytometric method for enhancing acute promyelocytic leukemia screening by multidimensional dot-plots.
    Kárai B; Habók M; Reményi G; Rejtő L; Ujfalusi A; Kappelmayer J; Hevessy Z
    Ann Hematol; 2019 Jun; 98(6):1413-1420. PubMed ID: 30830246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The clinical and laboratory features of acute promyelocytic leukemia: an analysis of 513 cases].
    Liang JY; Wu DP; Liu YJ; Ma QF; Gong JX; Zhu MQ; Xue YQ; Chen ZX
    Zhonghua Nei Ke Za Zhi; 2008 May; 47(5):389-92. PubMed ID: 18953948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secondary near-tetraploidy with double der(15)t(15;17) in acute promyelocytic leukemia in relapse.
    Morita Y; Takahashi A; Yamamoto K; Miki T; Murakami N; Miura O
    Cancer Genet Cytogenet; 2004 Mar; 149(2):131-6. PubMed ID: 15036889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The triple-negative (CD34-/HLA-DR-/CD11b-) profile rapidly and specifically identifies an acute promyelocytic leukemia.
    Rahman K; Gupta R; Singh MK; Sarkar MK; Gupta A; Nityanand S
    Int J Lab Hematol; 2018 Apr; 40(2):144-151. PubMed ID: 28984423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The diagnostic power of CD117, CD13, CD56, CD64, and MPO in rapid screening acute promyelocytic leukemia.
    Tran VT; Phan TT; Mac HP; Tran TT; Ho TT; Pho SP; Nguyen VN; Vo TM; Nguyen HT; Le TT; Vo TH; Nguyen ST
    BMC Res Notes; 2020 Aug; 13(1):394. PubMed ID: 32847610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunophenotype of adult and childhood acute promyelocytic leukaemia: correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases.
    Guglielmi C; Martelli MP; Diverio D; Fenu S; Vegna ML; Cantù-Rajnoldi A; Biondi A; Cocito MG; Del Vecchio L; Tabilio A; Avvisati G; Basso G; Lo Coco F
    Br J Haematol; 1998 Sep; 102(4):1035-41. PubMed ID: 9734655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morphology of acute promyelocytic leukemia with cytogenetic or molecular evidence for the diagnosis: characterization of additional microgranular variants.
    Neame PB; Soamboonsrup P; Leber B; Carter RF; Sunisloe L; Patterson W; Orzel A; Bates S; McBride JA
    Am J Hematol; 1997 Nov; 56(3):131-42. PubMed ID: 9371524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of CD34+, CD13+, CD33- cells, a rare subset of immature human hematopoietic cells.
    Gaipa G; Coustan-Smith E; Todisco E; Maglia O; Biondi A; Campana D
    Haematologica; 2002 Apr; 87(4):347-56. PubMed ID: 11940478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A hypogranular variant of acute promyelocytic leukaemia showing a heterogenic immunophenotype with CD34, CD2, HLA-DR positivity: a case report and review of the literature.
    Patteet L; Vermeulen K; Pieters K; Van Assche E; Vrelust I; Gaddiseur A; Berneman ZN; Van der Planken M
    Acta Clin Belg; 2012; 67(1):34-8. PubMed ID: 22480037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.